Zika vaccines and therapeutics: landscape analysis and challenges ahead
Abstract Background Various Zika virus (ZIKV) vaccine candidates are currently in development. Nevertheless, unique challenges in clinical development and regulatory pathways may hinder the licensure of high-quality, safe, and effective ZIKV vaccines. Discussion Implementing phase 3 efficacy trials...
Main Authors: | Annelies Wilder-Smith, Kirsten Vannice, Anna Durbin, Joachim Hombach, Stephen J. Thomas, Irani Thevarjan, Cameron P. Simmons |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12916-018-1067-x |
Similar Items
-
Zika vaccines and therapeutics: landscape analysis and challenges ahead
by: Wilder-Smith, Annelies, et al.
Published: (2018) -
Zika in travellers 1947-2017 : a systematic review
by: Wilder-Smith, Annelies, et al.
Published: (2020) -
Zika Virus from the Perspective of Observational Studies: a Review
by: Tayyab Saleem, et al.
Published: (2023-02-01) -
Current trends in Zika vaccine development
by: Francisco A. Lagunas-Rangel, et al.
Published: (2017-07-01) -
Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity
by: Yongkang Chen, et al.
Published: (2020-01-01)